Maria Carrara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maria Carrara has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Buriani
Maria Paola Belloni Center for Personalized Medicine, Data Medica Group (Synlab Limited), 35100 Padova, Italy
1 shared publication - Andrea Calderan
CNR Institute of Biomolecular Chemistry
1 shared publication - Barbara Biondi
Padova Unit Institute of Biomolecular Chemistry Padova Italy
1 shared publication G. Borin
CNR, Biopolymer Research Center,* Department of Organic Chemistry, University of Padua, via Marzolo 1, 35131 Padua, Italy
1 shared publication- Giulia Zorzi
Department of Laboratory Medicine, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium
1 shared publication - Gregorio Peron
Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy
1 shared publication
Latest Publications
- Open Access
- 1 June 2018
- Published by Taylor & Francis in Clinical and Experimental Gastroenterology
- Vol. ume 11, 243-248
Retrospective analysis of a lactose breath test in a gastrointestinal symptomatic population of Northeast Italy: use of (H2+2CH4) versus H2 threshold
Background: Lactose malabsorption is normally evaluated by measuring exhaled H2 produced by intestinal flora, from unabsorbed lactose. However, differing microbiome composition can lead to the production of CH4 instead of H2; hence, some authors challenge the H2 method sensitivity and favor the evaluation of both intestinal gases. Aim: To compare different approaches to usage of a lactose breath test for lactose malabsorption diagnosis, after medical evaluation of gastrointestinal symptoms. Methods: In a retrospective observational study, we compared the 2 approaches in a population of 282 subjects in Northern Italy. Following oral lactose administration, exhaled samples were harvested every 30 minutes for 4 hours and prepared for H2 and CH4 analysis. Basal gas levels were subtracted from H2 and CH4 ppm and values at 4 hours and peaks were considered for analysis. Results: Applying the standard methodology, which takes separately into consideration H2 and CH4 produced in the intestinal lumen, the results indicated that 11.7% of the patients were diagnosed “positive” for hypolactasia, differently from what was expected. Conversely, taking into consideration the sum of H2 and CH4, the percentage increased to 62.8%, closer to the expected one. No significant differences were found when comparing the 2 groups for age, gender, or symptoms. The sizable difference between the 2 approaches is likely linked to gut microbiome variability, and consequently the different production of the 2 gases, in the population. Conclusion: The threshold normally used for lactose breath test should be reconsidered and changed, merging H2 and CH4 stoichiometric values to increase sensitivity.
- 1 June 2018
- Published by Taylor & Francis in Clinical and Experimental Gastroenterology
- Vol. ume 11, 243-248
Open AccessRetrospective analysis of a lactose breath test in a gastrointestinal symptomatic population of Northeast Italy: use of (H2+2CH4) versus H2 threshold
Background: Lactose malabsorption is normally evaluated by measuring exhaled H2 produced by intestinal flora, from unabsorbed lactose. However, differing microbiome composition can lead to the production of CH4 instead of H2; hence, some authors challenge the H2 method sensitivity and favor the evaluation of both intestinal gases. Aim: To compare different approaches to usage of a lactose breath test for lactose malabsorption diagnosis, after medical evaluation of gastrointestinal symptoms. Methods: In a retrospective observational study, we compared the 2 approaches in a population of 282 subjects in Northern Italy. Following oral lactose administration, exhaled samples were harvested every 30 minutes for 4 hours and prepared for H2 and CH4 analysis. Basal gas levels were subtracted from H2 and CH4 ppm and values at 4 hours and peaks were considered for analysis. Results: Applying the standard methodology, which takes separately into consideration H2 and CH4 produced in the intestinal lumen, the results indicated that 11.7% of the patients were diagnosed “positive” for hypolactasia, differently from what was expected. Conversely, taking into consideration the sum of H2 and CH4, the percentage increased to 62.8%, closer to the expected one. No significant differences were found when comparing the 2 groups for age, gender, or symptoms. The sizable difference between the 2 approaches is likely linked to gut microbiome variability, and consequently the different production of the 2 gases, in the population. Conclusion: The threshold normally used for lactose breath test should be reconsidered and changed, merging H2 and CH4 stoichiometric values to increase sensitivity.
- Open Access
- 1 April 1999
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 53 (4) , 442-452
Ion‐binding and pharmacological properties of Tyr6 and Tyr9 antamanide analogs
In order to investigate the antiproliferative properties of antamanide, we have synthesized and studied two antamanide analogs where the phenylalanine residue in positions 6 or 9 is substituted by tyrosine, their corresponding linear forms and the cyclic and linear des Phe5,Phe6–Tyr9–analogs. Antamanide and its biologically active synthetic analogs are able to form highly stable complexes with metal ions, particularly Na+, K+ and Ca2+. We studied the ion‐binding properties of the Tyr–antamanide analogs by CD and Tb3+‐mediated fluorescence in acetonitrile. In this medium the far‐and near‐UV CD spectra of the neat Tyr6–antamanide analog are very similar to that of the parent cyclic decapeptide. Substantial differences occur on the contrary in the CD spectra of the neat Tyr9–antamanide, particularly in the regions at 220 nm and 270–290 nm. In acetonitrile, as already found for antamanide, the interaction with the above‐mentioned metal ions always produces evident changes in the far‐ and near‐UV CD spectra of both analogs. On the contrary, the CD spectra of the linear deca‐ and octa‐ and of the cyclic octa‐analogs are affected by the presence of metal ions only in the near‐UV region. In the same solvent the Tb3+‐mediated fluorescence spectra of all the synthetic peptides are remarkably affected by the addition of ions. On the basis of the spectral total changes, by using either or both the spectroscopic techniques, it has been possible to determine the ion binding constants for all the linear and cyclic Tyr–antamanide analogs and to compare them with that of the parent peptide. The antitoxic and antiproliferative activities of these antamanide analogs have been tentatively correlated to their ion‐binding properties. A preliminary account of this work was given in (1).
- 1 April 1999
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 53 (4) , 442-452
Open AccessIon‐binding and pharmacological properties of Tyr6 and Tyr9 antamanide analogs
In order to investigate the antiproliferative properties of antamanide, we have synthesized and studied two antamanide analogs where the phenylalanine residue in positions 6 or 9 is substituted by tyrosine, their corresponding linear forms and the cyclic and linear des Phe5,Phe6–Tyr9–analogs. Antamanide and its biologically active synthetic analogs are able to form highly stable complexes with metal ions, particularly Na+, K+ and Ca2+. We studied the ion‐binding properties of the Tyr–antamanide analogs by CD and Tb3+‐mediated fluorescence in acetonitrile. In this medium the far‐and near‐UV CD spectra of the neat Tyr6–antamanide analog are very similar to that of the parent cyclic decapeptide. Substantial differences occur on the contrary in the CD spectra of the neat Tyr9–antamanide, particularly in the regions at 220 nm and 270–290 nm. In acetonitrile, as already found for antamanide, the interaction with the above‐mentioned metal ions always produces evident changes in the far‐ and near‐UV CD spectra of both analogs. On the contrary, the CD spectra of the linear deca‐ and octa‐ and of the cyclic octa‐analogs are affected by the presence of metal ions only in the near‐UV region. In the same solvent the Tb3+‐mediated fluorescence spectra of all the synthetic peptides are remarkably affected by the addition of ions. On the basis of the spectral total changes, by using either or both the spectroscopic techniques, it has been possible to determine the ion binding constants for all the linear and cyclic Tyr–antamanide analogs and to compare them with that of the parent peptide. The antitoxic and antiproliferative activities of these antamanide analogs have been tentatively correlated to their ion‐binding properties. A preliminary account of this work was given in (1).